1 |
Theodoropoulos, P. A., H. Polioudaki, O. Kostaki, S. P. Derdas, V. Georgoulias, C. Dargemont, and S. D. Georgatos. 1999. Taxol affects nuclear lamina and pore complex organization and inhibits import of karyophilic proteins into the cell nucleus. Cancer Res. 59, 4625-4633.
|
2 |
Vakifahmetoglu, H., M. Olsson, and B. Zhivotovsky. 2008. Death through a tragedy: mitotic catastrophe. Cell Death Differ. 15, 1153-1162.
DOI
|
3 |
Moll, U. M., G. Riou, and A. J. Levine. 1992. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Natl. Acad. Sci. 89, 7262-7266.
DOI
|
4 |
Nogales, E., F. J. Medrano, G. P. Diakun, G. R. Mant, E. Towns-Andrews, and J. Bordas. 1995. The effect of temperature on the structure of vinblastine-induced polymers of purified tubulin: detection of a reversible conformational change. J. Mol. Biol. 254, 416-430.
DOI
|
5 |
Polyak, K., Y. Xia, J. L. Zweier, K. W. Kinzler, and B. A. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389, 300-305.
DOI
|
6 |
Scatena, C. D., Z. A. Stewart, D. Mays, L. J. Tang, C. J. Keefer, S. D. Leach, and J. A. Pietenpol. 1998. Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest. J. Biol. Chem. 273, 30777-30784.
DOI
|
7 |
Shenberger, J. S. and P. S. Dixon. 1999. Oxygen induces S-phase growth arrest and increases p53 and p21(WAF1/CIP1) expression in human bronchial smooth-muscle cells. Am. J. Respir. Cell Mol. Biol. 21, 395-402.
DOI
ScienceOn
|
8 |
Strausfeld, U., J. C. Labbé, D. Fesquet, J. C. Cavadore, A. Picard, K. Sadhu, P. Russell, and M. Dorée. 1991. Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature 351, 242-245.
DOI
|
9 |
Taylor, W. R. and G. R. Stark. 2001. Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815.
DOI
|
10 |
Tesniere, A., T. Panaretakis, O. Kepp, L. Apetoh, F. Ghiringhelli, L. Zitvogel, and G. Kroemer. 2008. Molecular characteristics of immunogenic cancer cell death. Cell Death Differ. 15, 3-12.
DOI
|
11 |
Kawabe, T. 2004. G2 checkpoint abrogators as anticancer drugs. Mol. Cancer Ther. 3, 513-519.
|
12 |
King, K. L. and J. A. Cidlowski. 1995. Cell cycle and apoptosis: common pathways to life and death. J. Cell Biochem. 58, 175-180.
DOI
|
13 |
Kim, S. J., H. G. Kim, C. D. Oh, S. G. Hwang, W. K. Song, Y. J. Yoo, S. S. Kang, and J. S. Chun. 2002. p38 kinase-dependent and -independent Inhibition of protein kinase C zeta and -alpha regulates nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes. J. Biol. Chem. 277, 30375-30381.
DOI
|
14 |
Kim, S. J., S. G. Hwang, D. Y. Shinm, S. S. Kang, and J. S. Chun. 2002. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NF kappa B-dependent transcription and stabilization by serine 15 phosphorylation. J. Biol. Chem. 277, 33501-33508.
DOI
|
15 |
Kim, S. J., S. G. Hwang, I. C. Kim, and J. S. Chun. 2003. Actin cytoskeletal architecture regulates nitric oxide-induced apoptosis, dedifferentiation, and cyclooxygenase-2 expression in articular chondrocytes via mitogen-activated
protein kinase and protein kinase C pathways. J. Biol. Chem. 278, 42448-42456.
DOI
|
16 |
Knippschild, U., M. Oren, and W. Deppert. 1996. Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. Oncogene 12, 1755-1765.
|
17 |
Krysko, D. V., T. Vanden Berghe, K. D'Herde, and P. Vandenabeele. 2008. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 44, 205-221.
DOI
|
18 |
Kumagai, A. and W. G. Dunphy. 1991. The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system. Cell 64, 903-914.
DOI
|
19 |
Mansilla, S., W. Priebe, and J. Portugal. 2006. Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms. Cell Cycle 5, 53-60.
DOI
|
20 |
Fang, L., L. Shen, Y. Fang, Y. Hu, Q. He, and B. Yang. 2008. MZ3 can induce G2/M-phase arrest and apoptosis in human leukemia cells. J. Cancer Res. Clin. Oncol. 134, 1337-1345.
DOI
|
21 |
Firestein, G. S., M. Yeo, and N. J. Zvaifler. 1995. Apoptosis in rheumatoid arthritis synovium. J. Clin. Invest. 96, 1631-1638.
DOI
|
22 |
Hagting, A., C. Karlsson, P. Clute, M. Jackman, and J. Pines. 1998. MPF localization is controlled by nuclear export. EMBO J. 17, 4127-4138.
DOI
|
23 |
Henley, D., M. Isbill, R. Fernando, J. S. Foster, and J. Wimalasena. 2007. Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity. Cancer Chemother. Pharmacol. 59, 235-249.
DOI
|
24 |
Horwitz, S. B. 1992. Mechanism of action of taxol. Trends Pharmacol. Sci. 13, 134-136.
DOI
|
25 |
Hui, A., G. V. Kulkarni, W. L. Hunter, C. A. McCulloch, and T. F. Cruz. 1997. Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes. Arthritis Rheum. 40, 1073-1084.
DOI
|
26 |
Im, J. H. and S. J. Kim. 2009. Paclitaxel suppress dedifferentiation via mitogen-activated protein kinase pathway in rabbit articular chondrocyte. Korean J. Biomed. Lab. Sci. 15, 67-72.
|
27 |
Im, J. H. and S. J. Kim. 2009. Paclitaxel stimulate cyclooxygenase-2 expression via MAP kinase pathway in rabbit articular chondrocyte. Korean J. Biomed. Lab. Sci. 15, 141-146.
|
28 |
Ireland, C. M. and S. M. Pitman. 1995. Tubulin alteration in taxol-induced apoptosis parallel those observed with other drugs. Biochem. Pharmacol. 49, 1491-1499.
DOI
|
29 |
Jackson, J. R., D. R. Patrick, M. M. Dar, and P. S. Huang. 2007. Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat. Rev. Cancer 7, 107-117.
DOI
|
30 |
Erenpreisa, J. E., A. Ivanov, G. Dekena, A. Vitina, R. Krampe, T. Freivalds, G. Selivanova, and H. I. Roach. 2000. Arrest in metaphase and anatomy of mitotic catastrophe: mild heat shock in two human osteosarcoma cell lines. Cell Biol. Int. 24, 61-70.
DOI
|
31 |
Castedo, M., J. L. Perfettini, T. Roumier, K. Andreau, R. Medema, and G. Kroemer. 2004. Cell death by mitotic catastrophe: a molecular definition. Oncogene 23, 2825-2837.
DOI
|
32 |
Bhalla, K., A. M. Ibrado, E. Tourkina, C. Tang, M. E. Mahoney, and Y. Huang. 1993. Paclitaxel induced internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7, 563-568.
|
33 |
Blagosklonny, M. V. 2002. p53: an ubiquitous target of anticancer drugs. Int. J. Cancer 98, 161-166.
DOI
|
34 |
Casenghi, M., P. Meraldi, U. Weinhart, P. I. Duncan, R. Korner, and E. A. Nigg. 2003. Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. Dev. Cell 5, 113-125.
DOI
ScienceOn
|
35 |
Danesi, R., W. D. Figg, E. Reed, and C. E. Myers. 1995. Paclitaxel inhibits isoprenylation and induces apoptosis in PC-3 prostate cancer cells. Mol. Pharmcol. 47, 1106-1111.
|
36 |
Donaldson, K. L., G. Goolsby, P. A. Kiener, and A. F. Wahl. 1994. Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ. 5, 1041-1050.
|
37 |
Miyashita, T. and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
DOI
|
38 |
Wani, M. C., H. L. Taylor, M. E. Wall, P. Coggon, and A. T. McPhail. 1971. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93, 2325-2327.
DOI
|
39 |
Wiernik, P. H., E.L. Schwartz, J. J. Strauman, J. P. Dutcher, R. B. Lipton, and E. Paietta. 1987. Phase I clinical and pharmacokinetic study of taxol. Cancer. Res. 47, 2486-2493.
|
40 |
Wood, K., W. D. Cornwell, and J. R. Jackson. 2001. Past and future of the mitotic spindle as an oncology target. Curr. Opin. Pharmacol. 1, 370-377.
DOI
|